Kynamro
mipomersen · APOB (ASO)Applicant estimated safe starting dose from nonclinical results; method not specified
The public FDA and EMA reviews of Amondys 45 don't say how the first human dose was chosen. That rationale is in the IND, which is confidential, so it is missing for most approved products.
Find the highest dose with no adverse effects (NOAEL) in each animal species, convert it to a human equivalent dose, usually by body surface area, pick the most appropriate species, then divide by a safety factor (default 10) to get the maximum recommended starting dose.
NOAEL / key findings: Kidney tubular basophilia/vacuolation, degeneration; juvenile rat NOAEL 300 mg/kg (4x AUC); no kidney no-effect dose in mouse/rat (FDA pharmacology/toxicology review, p. 75)